typically like to find em BEFORE they run
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nvm I see u annotated your chart looks good! Thanks!
g what do you think to close the gap, done already or needs to touch upper .009s?
Sterling is the DD gem and georgie is the charting/technical gem of ihub..
Every time a stock is stuck during an overall uptrend and I sell just a little little tiny bit it always runs higher.. I did that here at .018 and it worked like a charm lol lol
Heck yeah and the volume was too solid for this to be anywhere near done.. expecting .05 range this week!
still in here with ya g it's looking like a wild ride coming!
8k from yesterday looks like the best news in ages, new director added to the company board with experience and connections with VERY deep pockets!!!! He'll probably know how to bring some value to the undervalued stock!!
Very good news these debt holders converted at a fixed price of .01 per common share (.10 per preferred share which can convert 1:10 into common = .01) this should run again soon they'd only agree to such a price if they believe the stock will be above that in the near term..
Nice volume today smitter! This one looks ready to breakout!!!!!
TXTM huge accumulation today indicative of a move next week
I think it's a worthy gamble here.... If it was such a scam why does it typically trade way less than 1% of the outstanding shares per day.... And as recently as 3.5 weeks ago they said the audit was still going on and claimed millions in revenues... Good gamble in the OTC in my opinion
I got the email notification and just ordered 2 cases, I guess due to weight shipping is only $2 less compared to one case..
Good stuff!!!
I agree, plenty of volume to clear that last noteholder too plus today's PR mentions more PRs to come.. plus they are reporting mad amounts of cash too bad they couldn't sell all their consulting shares for $12 million but $3.2 million is amazing
So they've verified more news coming, and final current noteholder until October was to have $25k converting which is probably 50m shares and may be just about cleared out... So we'll have more big news and no more noteholders shortly seems like a great buy here.. just gotta keep seeing the accumulation and we will be breaking out soon....
Absolutely agreed my bearded friend! There is a lot going for this one, I'm a little more biased in favor of it because I love the products too, in addition to the stock technically being at a great buy level.. but we've got a low OS, nice oversold chart, and a firm bottom established around .0019 multiple times, only down due to the recent AS increase. But volume has never been very high down here so mostly retail sellers getting out after the AS increase, and very little/light dilution. Run up will be sweet!!! PLSB!!
Nice georgie!!! My big takeaway from it is that their business is validated and they are dealing with a ton of cash.. I don't agree with how they are managing the cash here yet, but cash means options, and potential, which means the share price will catch up.... I think we see .003 by end of the week or if they do a PR with it tomorrow with some good meat then .005+...
Also the timing is great with the convertible debt running out until October, and maybe they'll pre pay that if they sign enough clients..
Nice, I told myself I was gonna wait till it was above .003 to order another case of drinks!
Anyone know any gas stations that sell Cabana drinks in the San Antonio area?
Looks like THNS just said no we're not moving and is dumping out the .0001s first time in a month
Nice 10mil hit at .0002
One tiny note paid off, several hundred thousand dollars toxic debt taken out in subsequent events in the 10Q.... I'm not a basher I won't keep commenting on it
I think we will see them closing the gap toward profitability... their focus seems to be on reducing expenses and being more efficient...sounds good to me
I agree I just looked at this to see if I wanted to buy and I see in the last Q pitiful revenues down big time from last year and the only explanation they offered in the Q was "less purchase order received from company distributors" .... well duh that is obvious..... and under subsequent events they took out several hundred thousand dollars worth of toxic debt....... this ones not for me.... maybe it'll still run since it's the OTC sometimes momo just shows up but I'm not a buyer...
Nice, it's been in this channel around .002 for quite a while now, and they are consistently expanding and releasing PRs.. So whenever it does start a long term bull run all this press will tie together nicely
Every (ok almost every) excellent stock run starts from an oversold depressed stock price like this with similar sentiments going around... Just saying. If everyone had nothing but good things to say about a stock it's usually more on the over valued side... We've got a fairly low OS here, a nice bottom formed, and a company working to reduce expenses and increase distribution on some very appealing tasty and refreshing drinks...
Not a single person says they hate the drinks because it's impossible. They are good!!!!
Starting to look like it's on a monster uptrend.. I'm thinking there's a reverse merger taking place that we need to find out more about!!!!!
It's about time den!!!! for comparison purposes, BLD'V did a similar monster churn at these levels for a billion or so shares volume before breaking to .005+!!!!!
Might as well do keg stands during the countdown to .002 break lol
LOL.... I am a happy camper.. Literally..I am camping
The volume here suggests round 2 is on deck
Wow I'm finally at/above break even here! Funny how good just breaking even can feel! Let's go SVTE!!!!!!
It's got a unique taste that seems like it could really be mainstream... Maybe if we could get a celebrity endorsement or some more advertising this could really get wild
Some huge buys.. So thin.. Likely .10+ coming soon
Great wisdom georgie! I agree with all points but the bonus here is I really like their products! I thought limeade was a lame idea and saved those for last out of the variety case I'd bought, but then the plain limeade was my favorite one! Really good stuff!!!!
I think it's a good buy here because the effort to turn things around is being made right now, decreasing expenses, finding new distribution. Will it be successful in the long haul? Who knows... But should rebound from here in the meantime. Plenty of penny stocks with nothing whatsoever trade higher than this
Some say big T trades like that are bad but OWC'P was T trading it's ass off around .003-.009 and it went to $2
Wonder why they didn't PR this... 20% of profit to BBRD
http://m.tidalenergytoday.com/#newsitem-26416
Basically makes the stock a risk free waiting game until huge riches are realized... Waiting for our rights to generate $$$$$ without us needing to pay upfront costs
Fly let's take a trip down memory lane here.... We were both long in ICPA years ago where I think we draw some chart similarities to here although nothing else about the companies can be compared. That went .001-.006 and settled at .003 for the three longest months ever, before breaking to .06 or another 2000%. Here we broke .01-.12 and settled around .055 since the beginning of April, and our three months in this sideways consolidation holding pattern ends at the end of the month, when preclinical cardiac study results are due by. Coincidence??? I think not, lol!!!!!
If you really own nearly 30% of this company I don't think you would be using investorshub
I assumed this was referencing the financing but that the full amount wasn't allocated yet.. From the Q..
In addition, management has a commitment from a current lender for a total commitment of $2.7 million in the form of convertible notes. To date, the Company has received cash funding of $683,500 for $728,750 of convertible notes under this commitment. This commitment is subject to the Company not taking any variable financing from any other investor or lender.
Always nice to go back and read the PR that laid out the long term plan from last fall... Even better seeing it executed upon commencing several new preclinical studies recently.. my guess is the insider buying is the precursor to positive results from the cardiac study which could be released any day, and that is the precursor to uploading to a higher exchange as it starts us on a long term uptrend... First we moved .01-.12 and settled at .05/.06 range next we may go to .50 and settle around the .20s until the next leg and so on.. predictions are fun and all but I am just excited!!!!!
Endonovo Signs Term Sheet for $5 Million to Redeem All Outstanding Convertible Notes and Prepare to Uplist Its Common Stock
Financing to be Used for the Development of a Portfolio of Treatments for Vascular Diseases and Ischemic Injuries Using Endonovo's Immunotronics Platform
LOS ANGELES, CA--(Marketwired - Nov 28, 2016) - Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a developer of non-invasive electroceuticals for the treatment of inflammatory conditions and diseases in vital organs, today announced that it has signed a term sheet with a single strategic healthcare investor for $5 million in Series B Preferred Stock financing to redeem all of its outstanding convertible notes, fund several pre-clinical studies targeting vascular diseases and ischemic injuries in vital organs and to prepare to uplist the Company's common stock onto a national stock exchange.
The financing, subject to the signing of a definitive agreement, will be used to buy back approximately $2.2 million in Company convertible notes in order to preserve shareholder value, prevent additional dilution from the conversion of notes payable and to strengthen the Company's balance sheet. The strategic healthcare investor is serving as lead investor in a larger $15 million proposed financing to uplist the Company's common stock onto a national stock exchange in the first half of 2017.
Additionally, Endonovo plans to use the proceeds from the financing to fund the development of a portfolio of treatments for vascular diseases, including critical limb ischemia and ischemic ulcers, as well as treatments targeting vascular ischemia and reperfusion injuries in vital organs, including the liver, heart, kidneys, and central nervous system using the Company's non-invasive Immunotronics™ platform. The Company is preparing to conduct the first of several pre-clinical trials in the first quarter of 2017.
The Company's Immunotronics™ platform, which uses time variant magnetic pulses to illicit anti-inflammatory responses in cells and tissues and promotes tissue regeneration, has demonstrated significant potential in pre-clinical studies of acute inflammation and bone regeneration. Endonovo is now developing its Immunotronics™ platform to target inflammatory conditions in vital organs and for regenerative medicine.
"We are very excited to work with a strategic investor, who recognizes the value of the Company and the significant potential of our non-invasive technology in the treatment of several very large unmet clinical needs," stated Endonovo Chairman and CEO Alan Collier.
"It is very important that we buy back all outstanding convertible notes in order to prevent dilution and preserve shareholder value. We believe that our stock is considerably undervalued," continued Mr. Collier.
"This round of financing allows us to fund our the development of portfolio of treatments targeting vascular diseases and ischemic injuries and strengthens our financial position to uplist our common stock onto a national stock exchange in the first half of next year," concluded Mr. Collier.